Cleared Special

K081066 - BRACHYTHERAPY SOURCE DEVICE, MODEL 9011 (FDA 510(k) Clearance)

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K081066 · Medi-Physics, Inc., Dba GE Healthcare · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2008
Decision
20d
Days
Class 2
Risk

K081066 is an FDA 510(k) clearance for the BRACHYTHERAPY SOURCE DEVICE, MODEL 9011. Classified as Seed, Isotope, Gold, Titanium, Platinum (product code IWG), Class II - Special Controls.

Submitted by Medi-Physics, Inc., Dba GE Healthcare (Princeton, US). The FDA issued a Cleared decision on May 5, 2008 after a review of 20 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5730 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medi-Physics, Inc., Dba GE Healthcare devices

Submission Details

510(k) Number K081066 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2008
Decision Date May 05, 2008
Days to Decision 20 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
87d faster than avg
Panel avg: 107d · This submission: 20d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code IWG Seed, Isotope, Gold, Titanium, Platinum
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.